Skip to main content

Want a detailed portfolio tracker?

Cns Pharmaceuticals (CNSP) P/E (2024 - 2026)

Cns Pharmaceuticals (CNSP) P/E from Jul 1, 2024 to Jun 3, 2026. The TTM Cns Pharmaceuticals (CNSP) P/E is -0.20. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Cns Pharmaceuticals (CNSP)

YearP/EChange
2026-0.20+44.06%
2025-0.14-70.99%
2024-0.49N/A

Comparison Cns Pharmaceuticals (CNSP) P/E with competitors

Cns Pharmaceuticals (CNSP) P/E is -0.20.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.84%
NBYStablecoin Development Corp0.10-150.36%
ENLVEnlivex Therapeutics Ltd0.15-173.99%
FGENFibroGen Inc0.24-218.24%
TRAWTraws Pharma Inc0.47-332.91%
FBIOFortress Biotech Inc0.71-447.79%
CHRSCoherus Biosciences Inc0.98-581.83%
ORMPOramed Pharmaceuticals Inc1.47-825.82%
AGENAgenus Inc2.05-1109.08%
VIVSVivoSim Labs Inc2.54-1349.13%
INVAInnoviva Inc3.19-1670.66%
CRMDCorMedix Inc3.65-1895.89%
ABEOAbeona Therapeutics Inc4.20-2171.41%
VXRTVaxart Inc4.26-2199.29%
CVACCureVac N.V.4.45-2289.93%
SRPTSarepta Therapeutics Inc4.62-2377.92%
GLPGGalapagos NV4.86-2493.48%
RIGLRigel Pharmaceuticals4.92-2523.39%
ZVRAZevra Therapeutics Inc4.97-2550.23%
ABUSArbutus Biopharma Corp5.69-2904.77%
CGENCompugen Ltd7.38-3737.39%
AUPHAurinia Pharmaceuticals Inc9.25-4657.36%
ACADAcadia Pharmaceuticals Inc9.59-4823.17%
OMEROmeros Corporation9.88-4968.69%
PLXProtalix BioTherapeutics Inc9.91-4981.35%
SPROSpero Therapeutics Inc10.73-5388.06%
ADMAAdma Biologics Inc11.33-5681.61%
SVASinovac Biotech Ltd11.44-5733.53%
TBPHTheravance Biopharma Inc11.78-5901.32%
HRMYHarmony Biosciences Holdings Inc12.18-6100.24%
TGTXTG Therapeutics Inc13.18-6592.36%
INCYIncyte Corp13.38-6692.17%
SABSSAB Biotherapeutics Inc14.06-7025.03%
XOMAXOMA Corp14.95-7462.23%
REGNRegeneron Pharmaceuticals Inc14.98-7479.47%
PBYIPuma Biotechnology Inc15.05-7514.05%
EXELExelixis Inc15.79-7880.75%
NAGENiagen Bioscience Inc16.35-8156.67%
CPRXCatalyst Pharmaceuticals Inc17.34-8644.26%
MDXGMimedx Group Inc17.38-8659.34%
ARGXArgen X SE23.07-11465.39%
HALOHalozyme Therapeutics Inc23.20-11528.94%
XOMAOXOMA Corp25.34-12585.21%
VRTXVertex Pharmaceuticals Inc25.66-12738.41%
XOMAPXOMA Corp25.67-12745.46%
CTMXCytomX Therapeutics Inc25.70-12759.15%
ASNDAscendis Pharma A/S26.35-13082.41%
RPRXRoyalty Pharma plc - Class A27.50-13644.63%
SLNOSoleno Therapeutics Inc29.02-14393.36%
LGNDLigand Pharmaceuticals Inc - Class B30.19-14970.32%
BMRNBiomarin Pharmaceutical Inc37.51-18576.63%
APLSApellis Pharmaceuticals Inc39.02-19322.40%
KRYSKrystal Biotech Inc39.70-19655.61%
GMABGenmab40.20-19904.87%
ONCBeiGene Ltd67.03-33118.46%
TECHBio-Techne Corp68.59-33890.94%
VCELVericel Corp80.63-39819.15%
PHARPharming Group N.V.87.74-43322.11%
ALNYAlnylam Pharmaceuticals Inc124.93-61644.20%
TLXTelix Pharmaceuticals Ltd139.89-69012.24%
CORTCorcept Therapeutics Inc158.39-78124.93%